Calvista Pharmaceuticals rise after FDA nod for Ekterly (Kalv)

JON DEID
July 7, 2025
business

[ad_1]

Blue capsules in the conveyor in a modern pharmaceutical factory. Tablets and capsule production process. Approach of the production line of medical drug production. — SweetBunfactory / Istock via Getty Images

Calvista Pharmacy (Nasdaq:Calf) The US FDA, 12 years and older and older adults and children began after the US FDA, plasma inhibitor, Ekterly (Sebetralstat) to treat hereditary anbioedem.
Staple gossip Will start in the ektherly

[ad_2]

Source link

Leave a ReplyCancel Reply